Commentary on “study of the prevalence of autoimmune thyroid disease in women with breast cancer”

Endocrine Practice

Volumn 22, Issue 1, 2016, Pages 114-116

  Sisti, Giovanni ^a   Di Tommaso, Mariarosaria ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST NEOPLASMS; FEMALE; HUMAN; THYROIDITIS, AUTOIMMUNE;

BREAST NEOPLASMS; FEMALE; HUMANS; THYROIDITIS, AUTOIMMUNE;

EID: 84981288414     PISSN: 1530891X     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP151035.CO     Document Type: Review

References (29)

1. Freitas VGM, Vissoci GM, Pinto RM, Lajolo PP, Jorge PT. Study of the prevalence of autoimmune thyroid disease in women with breast cancer. Endocr Pract. 2016;22:16-21.
2. Sommers SC. Endocrine abnormalities in women with brest cancer. Lab Invest. 1955;4:160-174.
3. Goldman MB, Monson RR, Maloof F. Benign thyroid diseases and the risk of death from breast cancer. Oncology. 1992;49:461-466.
4. Weiss HA, Brinton LA, Potischman NA, et al. Breast cancer risk in young women and history of selected medical conditions. Int J Epidemiol. 1999;28:816-823.
5. Abe R, Taneichi Y, Kumagaya N, Terui K. Thyroid gland function on breast neoplasm [in Japanese]. Horumon To Rinsho. 1975;23:133-136.
6. Rose DP, Davis TE. Plasma thyroid-stimulating hormone and thyroxine concentrations in breast cancer. Cancer. 1978;41:666-669.
7. Rose DP Davis TE. Plasma triiodothyronine concentrations in breast cancer. Cancer. 1979;43:1434-1438.
8. Giani C, Fierabracci P, Bonacci R, et al. Relationship between breast cancer and thyroid disease: relevance of autoimmune thyroid disorders in breast malignancy. J Clin Endocrinol Metab. 1996;81:990-994.
9. Shering SG, Zbar AP, Moriarty M, McDermott EW, O'Higgins NJ, Smyth PP. Thyroid disorders and breast cancer. Eur J Cancer Prev. 1996;5:504-506.
10. Smyth PP, Shering SG, Kilbane MT, et al. Serum thyroid peroxidase autoantibodies, thyroid volume, and outcome in breast carcinoma. J Clin Endocrinol Metab. 1998;83:2711-2716.
11. Humphrey LJ, Swerdlow M. The relationship of breast disease to thyroid disease. Cancer. 1964;17:1170-1173.
12. Maruchi N, Annegers JF, Kurland LT. Hashimoto's thyroiditis and breast cancer. Mayo Clin Proc. 1976;51:263-265.
13. Mittra I, Perrin J, Kumaoka S. Thyroid and other autoantibodies in British and Japanese women: an epidemiological study of breast cancer. Br Med J, 1976;1:257-259.
14. Brinton LA, Hoffman DA, Hoover R, Fraumeni JF Jr. Relationship of thyroid disease and use of thyroid supplements to breast cancer risk. J Chronic Dis. 1984;37:877-893.
15. Sarlis NJ, Gourgiotis L, Pucino F, Tolis GJ. Lack of association between Hashimoto thyroiditis and breast cancer: a quantitative research synthesis. Hormones (Athens). 2002; 1:35-41.
16. Hardefeldt PJ, Eslick GD, Edirimanne S. Benign thyroid disease is associated with breast cancer: a meta-analysis. Breast Cancer Res Treat. 2012;133:1169-1177.
17. Chen YK, Lin CL, Chang YJ, et al. Cancer risk in patients with Graves' disease: a nationwide cohort study. Thyroid. 2013;23:879-884.
18. Ditsch N, Liebhardt S, Von Koch F, et al. Thyroid function in breast cancer patients. Anticancer Res. 2010;30:1713-1717.
19. Prinzi N, Baldini E, Sorrenti S, et al. Thyroid autoantibodies and breast cancer. Asian Pac J Cancer Prev. 2014; 15:10999.
20. Shi XZ, Jin X, Xu P, Shen HM. Relationship between breast cancer and levels of serum thyroid hormones and antibodies: a meta-analysis. Asian Pac J Cancer Prev. 2014;15:6643-6647.
21. Fiore E, Giustarini E, Mammoli C, et al. Favorable predictive value of thyroid autoimmunity in high aggressive breast cancer. J Endocrinol Invest. 2007;30:734-738.
22. Kemal Y, Demirag G, Ekiz K, Yucel I. Antithyroid peroxidase antibody positivity is associated with lower incidence of metastasis in breast cancer. Mol Clin Oncol. 2015;3:629-632.
23. Cengiz O, Bozkurt B, Unal B, et al. The relationship between prognostic factors of breast cancer and thyroid disorders in Turkish women. J Surg Oncol. 2004;87:19-25.
24. Jiskra J, Barkmanova J, Limanova Z, et al. Thyroid autoimmunity occurs more frequently in women with breast cancer compared to women with colorectal cancer and controls but it has no impact on relapse-free and overall survival. Oncol Rep. 2007;18:1603-1611.
25. Dülger H, Alici S, Algün E, et al. Antithyroid antibody levels in patients with breast cancer. Eur J Gen Med. 2004; 1:11-14.
26. Muller I, Pinchera A, Fiore E, et al. High prevalence of breast cancer in patients with benign thyroid diseases. J Endocrinol Invest. 2011;34:349-352.
27. Dohán O, De la Vieja A, Paroder V, et al. The sodium/ iodide symporter (NIS): characterization, regulation, and medical significance. Endocr Rev. 2003;24:48-77.
28. Peyrottes I, Navarro V, Ondo-Mendes A, et al. Immunoanalysis indicates that the sodium iodide symporter is not overexpressed in intracellular compartments in thyroid and breast cancers. Eur J Endocrinol. 2009;160: 215-225.
29. Nogueira CR, Brentani MM. Triiodothyronine mimics the effects of estrogen in breast cancer cell lines. J Steroid Biochem Mol Biol. 1996;59:271-279.